source
- FDA begins review of Roche’s experimental multiple sclerosis pill fenebrutinibThe FDA has accepted Roche's application for fenebrutinib, an experimental oral therapy for multiple sclerosis, and has started a priority review. The review will evaluate the drug in both relapsi…
- U.S. plan to cut Medicaid for legal immigrants, including refugees and trafficking victims, takes effect Oct. 1Hundreds of thousands of lawfully present immigrants could lose Medicaid coverage beginning Oct. 1, according to state data. The change is part of the One Big Beautiful Bill Act, a Republican effor…